ISRCTN87407792已完成未知
SeconDary Stroke PreVEntion ThRough Pathway ManagemenT (DiVERT Stroke)
Medtronic (United States)0 个研究点目标入组 6,536 人开始时间: 2021年3月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6,536
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 01/09/2022:
- •US Inclusion Criteria:
- •1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion hospitalization between 2017 – 2019
- •2. Age =18 years
- •UK Inclusion Criteria:
- •1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion hospitalization between 2019-2020. If ischemic stroke sub-type classification proves to be difficult (i.e., small sample size), patients with an ischemic stroke from 2017-2019 will be included.
- •2. Age =18 years
- •Previous inclusion criteria from 20/05/2021 to 01/09/2022:
- •1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion
- •hospitalization between 2017 – 2019
- •2. Age =18 years
- •Previous inclusion criteria:
- •1. Patients with a cryptogenic stroke hospitalization defined by ICD-10 I63.9 between 2017 – 2019
- •2. Age =18 years
排除标准
- •Current exclusion criteria as of 20/05/2021:
- •Does not meet inclusion criteria
- •Previous exclusion criteria:
- •1. Any history of the following through index stroke:
- •1.1. Lacunar stroke
- •1.2. Large artery atherosclerosis
- •1.3. Diagnosis of AF or atrial flutter
- •1.4. Ablation for AF or atrial flutter
- •1.5. OAC use
- •1.6. Methamphetamines drug use
- •1.7. Mechanical heart valves
- •1.8. Rheumatic heart disease
- •1.9. Mitral stenosis
- •1.10. Ischemic cardiomyopathy
- •1.11. Dilated cardiomyopathy
- •1.12. ST-elevation MI
- •1.13. Vasculitis
- •1.14. End stage renal disease
- •1.15. ICM implant prior to index event
- •2. VT Ablation within 30 days of index event
- •3. Non-AF left atrial or ventricular ablation within 30 days of index event
- •4. Any of the following within 30 days pre to 90 days post index stroke:
- •4.1. Carotid artery stenting
- •4.2. Carotid endarterectomy
- •4.3. Carotid artery stenosis or occlusion
- •4.4. ASD closure device insertion
研究者
相似试验
进行中(未招募)
不适用
Secondary stroke prevention through pathway managementCirculatory SystemStrokeISRCTN43724416Medtronic (United States)1,500
招募中
不适用
Prevention of secondary stroke by risk factor control and medication adherenceCTRI/2021/10/037432Department of Health and Family Welfare
已完成
不适用
Stop Stroke: The South London Secondary Prevention ProgrammeCirculatory SystemStrokeISRCTN10730637King's College London (UK)450
已完成
不适用
Evaluation of Secondary Prevention of Stroke Study in the Outpatient Cliniccerebrovascular accident10007963StrokeNL-OMON35302Academisch Medisch Centrum200
进行中(未招募)
不适用
Prevention of one sort of cerebral vascular stroke (small subcortical strokes) in patients who already suffered one beforeEUCTR2005-003242-34-ESational Institutes of Neurological Disorders: Stroke2,500
